Which are the antibodies to watch in 2013? (Q43175696)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 December 2012

edit

Language	Label	Description	Also known as
English	Which are the antibodies to watch in 2013?	scientific article published on 19 December 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

editorial

0 references

title

Which are the antibodies to watch in 2013? (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

main subject

antibody

1 reference

based on heuristic

inferred from title

author

Janice M. Reichert

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

publication date

19 December 2012

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

published in

Monoclonal Antibodies

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

volume

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

page(s)

1-4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

cites work

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

25 May 2018

Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 In

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

25 May 2018

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564874

retrieved

15 August 2018

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23254906

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.4161/MABS.22976

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

PMC publication ID

3564874

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

PubMed publication ID

23254906

1 reference

stated in

Europe PubMed Central

PMC publication ID

3564874

retrieved

15 November 2017

ResearchGate publication ID

233958149

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43175696&oldid=1600875182"